Applied Genetic Technologies

YTD

ALL

Why Robinhood?

You can watch AGTC and buy or sell other stocks, ETFs, and their options commission-free!

About AGTC

Applied Genetic Technologies Corp. is a clinical stage biotechnology company, which engages in the usage of a gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. The firm also focuses on conducting clinical trials in the field of ophthalmology, optogenetics, adrenoleukodystrophy, and otology.

CEO

David A. Fellows

CEODavid A. Fellows

Employees

—

Employees—

Headquarters

Alachua, Florida

HeadquartersAlachua, Florida

Founded

1999

Founded1999

Employees

—

Employees—

AGTC Key Statistics

Market cap

26.62M

Market cap26.62M

Price-Earnings ratio

-0.28

Price-Earnings ratio-0.28

Dividend yield

—

Dividend yield—

Average volume

1.38M

Average volume1.38M

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$2.83

52 Week high$2.83

52 Week low

$0.2303

52 Week low$0.2303

People also own

Based on the portfolios of people who own AGTC. This list is generated using Robinhood data, and it’s not a recommendation.

Zomedica

Bionano Genomics

SNDL

Citius Pharmaceuticals

Senseonics

Tonix Pharmaceuticals